Browse online exclusive articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Marlene Moster, MD, will deliver the Richard L. Lindstrom, MD, Lecture at the ASCRS Annual Meeting. In her lecture, titled “Glaucoma Surgery: The Next Level,” Dr. Moster plans to discuss problems with current glaucoma surgical options. She will also highlight future devices and techniques that may help make glaucoma surgery more efficacious.
Digital Day, sponsored by the Digital Ophthalmic Society (DOS) and taking place in conjunction with ASCRS Subspecialty Day today, is a full-day, non-CME program centered around novel, technology-driven solutions with functional integration that are going to push ophthalmology forward.
There will be several featured Government Relations activities at the ASCRS Annual Meeting in San Diego, California, including the eyePAC Reception on May 5 and the Government Relations symposium featuring political analyst and journalist Mark McKinnon on May 6.
Over the last few years, new, tech-based options have joined traditional therapies for the treatment of amblyopia. All of the available options have their pros and cons, making patient selection especially important.
This year, the ASCRS Film Festival moves to Sunday night at the Annual Meeting. EyeWorld spoke to Shachar Tauber, MD, and Denise Visco, MD, co-chairs of the event, about why they enjoy the Film Festival and what they’re looking forward to this year.
The ASCRS Annual Meeting, taking place May 5–8 in San Diego, California, will feature a variety of exciting educational symposia on Saturday, Sunday, and Monday.
The opportunities for young eye surgeons (YES members) at the ASCRS Annual Meeting continue to expand. At the upcoming Annual Meeting in San Diego, California, May 5–8, attendees can expect a full day of YES labs, YES programming, as well as events throughout the rest of the meeting.
The first-in-human trial and data for suprachoroidal outflow enhancement using a novel micro-interventional technology and first-in-class biostenting approach developed by Sean Ianchulev, MD, MPH, was published online in the British Journal of Ophthalmology in January.
“A fundamental and unanswered question concerning all MIGS devices is whether they have any measurable ability to help POAG patients retain their vision.” The authors of a study published in the American Journal of Ophthalmology sought to answer this question. The study is a post-hoc visual field analysis of the 5-year HORIZON trial.
Bala Ambati, MD, won The Winning Pitch Challenge during the session at the ASCRS Annual Meeting in 2019. His company, iVeena, presented the IVMED-80, a pharmacologic drop treatment for keratoconus.